Literature DB >> 20849256

Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data.

Timothy M Zagar1, James R Oleson, Zeljko Vujaskovic, Mark W Dewhirst, Oana I Craciunescu, Kimberly L Blackwell, Leonard R Prosnitz, Ellen L Jones.   

Abstract

Hyperthermia has long been used in combination with radiation for the treatment of superficial malignancies, in part due to its radiosensitising capabilities. Patients who suffer superficial recurrences of breast cancer, be it in their chest wall following mastectomy, or in their breast after breast conservation, typically have poor clinical outcomes. They often develop distant metastatic disease, but one must not overlook the problems associated with an uncontrolled local failure. Morbidity is enormous, and can significantly impair quality of life. There is no accepted standard of care in treating superficial recurrences of breast cancer, particularly in patients that have previously been irradiated. There is a substantial literature regarding the combined use of hyperthermia and radiotherapy for these superficial recurrences. Most of it is retrospective in nature, but there are several larger phase III randomised trials that show an improved rate of clinical complete response in patients treated with both modalities. In this review article, we will highlight the important prospective data that has been published regarding the combined use of hyperthermia and radiation.

Entities:  

Mesh:

Year:  2010        PMID: 20849256      PMCID: PMC2956421          DOI: 10.3109/02656736.2010.487194

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  45 in total

Review 1.  Postmastectomy radiation therapy: indications and controversies.

Authors:  Marie Catherine Lee; Reshma Jagsi
Journal:  Surg Clin North Am       Date:  2007-04       Impact factor: 2.741

2.  Locally recurrent carcinoma of the breast. Results of radiation therapy.

Authors:  F C Chu; F J Lin; J H Kim; S H Huh; C J Garmatis
Journal:  Cancer       Date:  1976-06       Impact factor: 6.860

3.  Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.

Authors:  Joseph Ragaz; Ivo A Olivotto; John J Spinelli; Norman Phillips; Stewart M Jackson; Kenneth S Wilson; Margaret A Knowling; Christopher M L Coppin; Lorna Weir; Karen Gelmon; Nhu Le; Ralph Durand; Andrew J Coldman; Mohamed Manji
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

4.  Superficial chest wall recurrences of breast cancer: prognostic treatment factors for combined radiation therapy and hyperthermia.

Authors:  H M Seegenschmiedt; U L Karlsson; R Sauer; L W Brady; M Herbst; B E Amendola; A M Markoe; S A Fisher; B Micaily
Journal:  Radiology       Date:  1989-11       Impact factor: 11.105

5.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

Authors:  M Overgaard; M B Jensen; J Overgaard; P S Hansen; C Rose; M Andersson; C Kamby; M Kjaer; C C Gadeberg; B B Rasmussen; M Blichert-Toft; H T Mouridsen
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

6.  Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

Authors:  M Overgaard; P S Hansen; J Overgaard; C Rose; M Andersson; F Bach; M Kjaer; C C Gadeberg; H T Mouridsen; M B Jensen; K Zedeler
Journal:  N Engl J Med       Date:  1997-10-02       Impact factor: 91.245

7.  Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.

Authors:  Hanne M Nielsen; Marie Overgaard; Cai Grau; Anni R Jensen; Jens Overgaard
Journal:  J Clin Oncol       Date:  2006-04-17       Impact factor: 44.544

8.  Clinical results of irradiation combined with local hyperthermia.

Authors:  C A Perez; G Nussbaum; B Emami; D VonGerichten
Journal:  Cancer       Date:  1983-11-01       Impact factor: 6.860

Review 9.  The efficacy of caelyx and hyperthermia for anticancer treatment.

Authors:  Vasilios E Kouloulias; Georgios V Koukourakis; Aristides K Petridis; Ioannis Kouvaris; Athanasios D Gouliamos
Journal:  Recent Pat Anticancer Drug Discov       Date:  2007-11       Impact factor: 4.169

10.  Randomized trial of one versus two adjuvant hyperthermia treatments per week in patients with superficial tumours.

Authors:  K Engin; L Tupchong; D J Moylan; G A Alexander; F M Waterman; L Komarnicky; R E Nerlinger; D B Leeper
Journal:  Int J Hyperthermia       Date:  1993 May-Jun       Impact factor: 3.914

View more
  26 in total

Review 1.  Review of the progress toward achieving heat confinement-the holy grail of photothermal therapy.

Authors:  Wangzhong Sheng; Sha He; William J Seare; Adah Almutairi
Journal:  J Biomed Opt       Date:  2017-08-01       Impact factor: 3.170

2.  Concerning the final report "Hyperthermia: a systematic review" of the Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, March 2010.

Authors:  R Sauer; H Creeze; M Hulshof; R Issels; O Ott
Journal:  Strahlenther Onkol       Date:  2012-03       Impact factor: 3.621

3.  Hyperthermia sensitization and proton beam triggered liposomal drug release for targeted tumor therapy.

Authors:  R Fernando; D Maples; L K Senavirathna; Y Zheng; J C Polf; E R Benton; K E Bartels; D Piao; A Ranjan
Journal:  Pharm Res       Date:  2014-05-23       Impact factor: 4.200

Review 4.  Role of radiation therapy in palliative care of the patient with cancer.

Authors:  Stephen T Lutz; Joshua Jones; Edward Chow
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

5.  Nanoparticle-mediated hyperthermia in cancer therapy.

Authors:  Dev Kumar Chatterjee; Parmeswaran Diagaradjane; Sunil Krishnan
Journal:  Ther Deliv       Date:  2011-08

Review 6.  Heating technology for malignant tumors: a review.

Authors:  H Petra Kok; Erik N K Cressman; Wim Ceelen; Christopher L Brace; Robert Ivkov; Holger Grüll; Gail Ter Haar; Peter Wust; Johannes Crezee
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

7.  Conductive thermal ablation of 4T1 murine breast carcinoma reduces severe hypoxia in surviving tumour.

Authors:  Beata D Przybyla; Gal Shafirstein; Nathan A Koonce; Jessica S Webber; Robert J Griffin
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.914

Review 8.  Gold nanoparticles in breast cancer treatment: promise and potential pitfalls.

Authors:  Jihyoun Lee; Dev Kumar Chatterjee; Min Hyuk Lee; Sunil Krishnan
Journal:  Cancer Lett       Date:  2014-02-17       Impact factor: 8.679

Review 9.  Diagnostic and therapeutic management of hepatocellular carcinoma.

Authors:  Francesco Bellissimo; Marilia Rita Pinzone; Bruno Cacopardo; Giuseppe Nunnari
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

10.  Model-based feasibility assessment and evaluation of prostate hyperthermia with a commercial MR-guided endorectal HIFU ablation array.

Authors:  Vasant A Salgaonkar; Punit Prakash; Viola Rieke; Eugene Ozhinsky; Juan Plata; John Kurhanewicz; I-C Joe Hsu; Chris J Diederich
Journal:  Med Phys       Date:  2014-03       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.